Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives (Q38494198)

3 September 2017

1 reference

title

Non-invasive diagnostic approach to non-alcoholic fatty liver disease: current evidence and future perspectives (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

3 September 2017

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

based on heuristic

inferred from title

non-invasive diagnostics

1 reference

Davide Festi

1

0 references

Antonio Colecchia

6

object named as

Antonio Colecchia

1 reference

3 September 2017

Ramona Schiumerini

2

1 reference

3 September 2017

Giovanni Marasco

3

1 reference

3 September 2017

Eleonora Scaioli

4

1 reference

3 September 2017

Francesca Pasqui

5

1 reference

3 September 2017

20 May 2015

1 reference

Expert Review of Gastroenterology & Hepatology

3 September 2017

1 reference

3 September 2017

9

1 reference

3 September 2017

1039-1053

1 reference

3 September 2017

8

1 reference

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

3 September 2017

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Epidemiology of non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Sonographic fatty liver, overweight and ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Nonalcoholic steatohepatitis: risk factors and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

A simple index of lipid overaccumulation is a good marker of liver steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

The "lipid accumulation product" performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Controlled attenuation parameter (CAP): a novel VCTE™ guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

An apoptosis panel for nonalcoholic steatohepatitis diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

OxNASH score correlates with histologic features and severity of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Comparison of blood tests for liver fibrosis specific or not to NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Transient elastography in patients with non-alcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Liver stiffness measurements in patients with different stages of nonalcoholic fatty liver disease: diagnostic performance and clinicopathological correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Feasibility of liver transient elastography with FibroScan using a new probe for obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Acoustic radiation force impulse-imaging and transient elastography for non-invasive assessment of liver fibrosis and steatosis in NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Value of acoustic radiation force impulse imaging elastography for non-invasive evaluation of patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Liver elasticity in NASH patients evaluated with real-time elastography (RTE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Magnetic resonance elastography of liver: technique, analysis, and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

Reliability of liver stiffness measurement in non-alcoholic fatty liver disease: the effects of body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17474124.2015.1049155

10.1586/17474124.2015.1049155

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference